AU7595300A - Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs - Google Patents
Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogsInfo
- Publication number
- AU7595300A AU7595300A AU75953/00A AU7595300A AU7595300A AU 7595300 A AU7595300 A AU 7595300A AU 75953/00 A AU75953/00 A AU 75953/00A AU 7595300 A AU7595300 A AU 7595300A AU 7595300 A AU7595300 A AU 7595300A
- Authority
- AU
- Australia
- Prior art keywords
- dogs
- cognitive dysfunction
- chewable tablet
- dysfunction syndrome
- treating cognitive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40153299A | 1999-09-22 | 1999-09-22 | |
US09401532 | 1999-09-22 | ||
PCT/US2000/025771 WO2001021178A2 (en) | 1999-09-22 | 2000-09-21 | Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7595300A true AU7595300A (en) | 2001-04-24 |
Family
ID=23588149
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU75953/00A Abandoned AU7595300A (en) | 1999-09-22 | 2000-09-21 | Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU7595300A (en) |
WO (1) | WO2001021178A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2884421B1 (en) | 2005-04-15 | 2007-08-10 | Virbac Sa | NEW MEANS FOR CONTROLLING BEHAVIORAL DISORDERS IN PETS |
JP2010504337A (en) * | 2006-09-20 | 2010-02-12 | メディベイション ニューロロジー, インコーポレイテッド | Hydrogenated pyrido [4,3-b] indoles such as dimebon for the treatment of cognitive impairment syndrome in dogs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4937076A (en) * | 1984-08-10 | 1990-06-26 | Combe Incorporated | Chewable aspirin and buffering material tablet and method for producing same |
PT760648E (en) * | 1994-05-20 | 2002-04-29 | Janssen Pharmaceutica Nv | TABLETS OF FLUBENDAZOLE OF MASTIGATION FOR DOMESTIC ANIMALS |
TW442287B (en) * | 1995-06-13 | 2001-06-23 | American Home Produits Corp | Organoleptically acceptable oral pharmaceutical composition comprising the S(+)1,8-diethyl-1-1,3,4,9-tetrahydropyrano[3,4-b] indole-1-acetic acid (Etodolac) |
ZA964928B (en) * | 1995-06-13 | 1997-12-10 | American Home Prod | Oral formulations of S(+)-etodolac. |
-
2000
- 2000-09-21 WO PCT/US2000/025771 patent/WO2001021178A2/en active Application Filing
- 2000-09-21 AU AU75953/00A patent/AU7595300A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001021178A3 (en) | 2002-07-11 |
WO2001021178A2 (en) | 2001-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003277270B2 (en) | Inorganic shaped bodies and methods for their production and use | |
AU3239800A (en) | Method and apparatus for improving access to literature | |
AU3372000A (en) | Stomach treatment apparatus and method | |
AU2373200A (en) | Apparatuses and methods for forming assemblies | |
AU6375399A (en) | Electromagnetic-field therapy method and device | |
AU1448601A (en) | Gerd treatment apparatus and method | |
AU1160801A (en) | Apparatus and method | |
AU2735200A (en) | Device and method for stimulating salivation | |
AU2002329022A1 (en) | Method and pharmaceutical composition for treating inflammation | |
AU7484500A (en) | Cargo-transfer apparatus and method | |
AU3877900A (en) | Compositions and methods for preventing and treating sexual dysfunctions | |
AUPP855599A0 (en) | Apparatus and method | |
AU5838700A (en) | Method for treating and preventing finger disorders | |
AU2562100A (en) | Waste treatment apparatus and methods | |
AU1530801A (en) | Waste treatment apparatus and methods | |
AU7595300A (en) | Method of treating cognitive dysfunction syndrome in dogs and chewable tablet for dogs | |
AU2744900A (en) | Method and apparatus for manufacturing design | |
AU1024301A (en) | Method and device for treating surfaces of objects | |
AU5406500A (en) | Method and device for producing pellets | |
AU7577700A (en) | Purification device and purification method | |
AU6099800A (en) | Structure forming apparatus and method | |
AU5438801A (en) | Method and device for cleaning areas of the pharynx | |
AU2461999A (en) | Pharmaceutical composition and method for treating di-hydroxytestosterone dependent conditions | |
AU1858301A (en) | Method and device for annealing flat bodies | |
AU3537601A (en) | Method and device for aligning bodies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |